Lipoma or sarcoma

Czech version

Authors: A. Ozaniak; R. Lischke
Authors‘ workplace: III. chirurgická klinika ; 1. LF UK a FN Motol, Praha ; III. chirurgická klinika 1. LF UK a FN Motol, Praha
Published in: Rozhl. Chir., 2025, roč. 104, č. 5, s. 185-190.
Category: Review
doi: https://doi.org/10.48095/ccrvch2025185

Overview

Sarcomas are rare malignant mesenchymal tumors, occurring both in the childhood and in adult population. The differential diagnosis of soft tissue lesions includes a wide range of tumors with different clinical manifestation and biological behaviour. Clinical examination of superficial lesions is insufficient and often leads to an underestimation of the extent of the disease. Correct diagnosis and operative technique are key parameters to avoid unnecessary excessive resections in benign tumors, or, on the contrary, non-radical procedures in malignant tumors. Many of the patients are examined late. Unplanned surgical resections represent a major problem in local control of the disease. The goal of this work is to increase the awareness of the medical professionals in the field of soft tissue tumors.

Keywords:

sarcoma – lipoma – mesenchymal tumor – centralization

Sources

1. Kolb L, Yarrarapu SN, Ameer MA et al. Lipoma. Treasure Island (FL): StatPearls Publishing 2023.

2. WHO. Soft tissue and bone tumours. 2020 [online]. Dostupné z: https://publications.iarc.fr/588.

3. Gatta G, Capocaccia R, Botta L et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet – a population-based study. Lancet Oncol 2017; 18(8): 1022–1039. doi: 10.1016/S1470-2045(17)30445-X.

4. Blay JY, Soibinet P, Penel N et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol 2017; 28(11): 2852–2859. doi: 10.1093/annonc/mdx484.

5. Blay JY, Honoré C, Stoeckle E et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol 2019; 30(7): 1143–1153. doi: 10.1093/annonc/mdz124.

6. Keung EZ, Chiang YJ, Cormier JN et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 2018; 124(23): 4495–4503. doi: 10.1002/cncr.31699.

7. Kamarajah SK, Baia M, Naumann DN et al. Association between centre volume and allocation to curative surgery and long-term survival for retroperitoneal sarcoma. BJS Open 2023; 7(4): zrad059. doi: 10.1093/bjsopen/zrad059.

8. Derbel O, Heudel PE, Cropet C et al. Survival impact of centralization and clinical guidelines for soft tissue sarcoma (a prospective and exhaustive population-based cohort). PLoS One 2017; 12(2): e0158406. doi: 10.1371/journal.pone.0158406.

9. Duarte AF, Sousa-Pinto B, Azevedo LF et al. Clinical ABCDE rule for early melanoma detection. Eur J Dermatol 2021; 31(6): 771–778. doi: 10.1684/ejd.2021.4171.

10. Ozaniak A, Vachtenheim J, Chmelova R et al. Rare pseudosarcomatous lesions posing diagnostic challenges: histopathologic examination as a dominant tool preventing misdiagnosis of proliferative fasciitis. Cureus 2022; 14(6): e25770. doi: 10.7759/cureus.25770.

11. Aga P, Singh R, Parihar A et al. Imaging spectrum in soft tissue sarcomas. Indian J Surg Oncol 2011; 2(4): 271–279. doi: 10.1007/s13193-011-0095-1.

12. Gronchi A, Miah AB, Dei Tos AP et al. Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021; 32(11): 1348–1365. doi: 10.1016/j.annonc.2021.07.006.

13. Nardo L, Abdelhafez YG, Acquafredda F et al. Qualitative evaluation of MRI features of lipoma and atypical lipomatous tumor: results from a multicenter study. Skeletal Radiol 2020; 49(6): 1005–1014. doi: 10.1007/s00256-020-03372-5.

14. O’Donnell PW, Griffin AM, Eward WC et al. Can experienced observers differentiate between lipoma and well-differentiated liposarcoma using only MRI? Sarcoma 2013; 2013: 982784. doi: 10.1155/2013/982784.

15. Moulin B, Messiou C, Crombe A et al. Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European experts. Eur J Surg Oncol 2022; 48(3): 518–525. doi: 10.1016/j.ejso.2021.10.009.

16. Birgin E, Yang C, Hetjens S et al. Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: a systematic review and meta-analysis. Cancer 2020; 126(9): 1917–1928. doi: 10.1002/cncr.32735.

17. Berger-Richardson D, Swallow CJ. Needle tract seeding after percutaneous biopsy of sarcoma: risk/benefit considerations. Cancer 2017; 123(4): 560–567. doi: 10.1002/cncr.30370.

18. Wilkinson MJ, Martin JL, Khan AA et al. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol 2015; 22(3): 853–858. doi: 10.1245/s10434-014-4059-x.

19. Trans-Atlantic RPS Working Group. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015; 22(1): 256–263. doi: 10.1245/s10434-014-3965-2.

20. Ray-Coquard I, Montesco MC, Coindre JM et al. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol 2012; 23(9): 2442–2449. doi: 10.1093/annonc/mdr610.

21. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106–120.

22. Crago AM, Cardona K, Koseła-Paterczyk H et al. Management of myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Surg Oncol Clin N Am 2022; 31(3): 419–430. doi: 10.1016/j.soc.2022.03.006.

23. Sambri A, Caldari E, Fiore M et al. Margin assessment in soft tissue sarcomas: review of the literature. Cancers (Basel) 2021; 13(7): 1687. doi: 10.3390/cancers13071687.